Loading...
Artivion Q1 2025 Earnings Report
Artivion reported its financial results for the first quarter ended March 31, 2025.
Key Takeaways
Artivion, Inc. reported a 2% increase in total revenues to $99.0 million for the first quarter of 2025 compared to the same period last year, driven by growth in stent grafts, On-X, and BioGlue, despite a net loss of $(0.5) million.
Achieved revenue of $99.0 million in Q1 2025, a 2% increase on a GAAP basis and 4% on a non-GAAP constant currency basis compared to Q1 2024.
Reported a net loss of $(0.5) million, or $(0.01) per fully diluted share, with non-GAAP net income of $2.5 million, or $0.06 per fully diluted share.
Adjusted EBITDA increased 1% to $17.5 million in Q1 2025 compared to $17.3 million in Q1 2024.
Submitted the clinical module of the pre-market approval application (PMA) to the FDA for the AMDS Hybrid Prosthesis.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
Artivion is raising the midpoint of its revenue guidance for full year 2025, expecting growth of 11% to 14% on a constant currency basis compared to 2024, and adjusted EBITDA growth of 18% to 28%.
Positive Outlook
- Raising midpoint of full year 2025 revenue expectations.
- Expects full year 2025 revenue in the range of $423 million to $435 million.
- Anticipates revenue growth of 11% to 14% on a constant currency basis compared to 2024.
- Expects adjusted EBITDA growth of between 18% and 28% for the full year 2025.
- Anticipates adjusted EBITDA in the range of $84 million to $91 million for 2025.
Challenges Ahead
- Current exchange rates would provide incremental upside to as-reported revenue guidance range, but the Company is not revising FX assumptions due to ongoing volatility.
- Financial performance for 2025 and future periods is subject to identified risks.
- Forward-looking statements are subject to risks, uncertainties, estimates, and assumptions that may cause actual results to differ materially.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...